Interstitial lung abnormalities in rheumatoid arthritis are common and important

Chest

Volumn 146, Issue 1, 2014, Pages 8-10

  Fischer, Aryeh ^a   Cosgrove, Gregory P ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

AUTOIMMUNE DISEASE; BIOLOGICAL THERAPY; CLINICAL FEATURE; EDITORIAL; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOPATHOLOGY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG COMPLICATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURVIVAL TIME;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MORBIDITY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; WORLD HEALTH;

EID: 84903853108     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0030     Document Type: Editorial

References (14)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthri tis. N Engl J Med. 2011; 365 (23): 2205-2219.
2. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376 (9746): 1094-1108.
3. O'Dell JR. Th erapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004; 350 (25): 2591-2602.
4. Minaur NJ, Jacoby RK, Cosh JA, Taylor G, Rasker JJ. Outcome aft er 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. J Rheumatol Suppl. 2004; 69: 3-8.
5. Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A. Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol. 2004; 33 (4): 221-227.
6. Brown KK. Rheumatoid lung disease. Proc Am Th orac Soc. 2007; 4 (5): 443-448.
7. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010; 62 (6): 1583-1591.
8. Solomon JJ, Ryu JH, Tazelaar HD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med. 2013; 107 (8): 1247-1252.
9. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994; 21 (1): 33-36.
10. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthri tis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003; 62 (8): 722-727.
11. Bilgici A, Ulusoy H, Kuru O, Celenk C, Unsal M, Danaci M. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int. 2005; 25 (6): 429-435.
12. Zrour SH, Touzi M, Bejia I, et al. Correlations between highresolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine. 2005; 72 (1): 41-47.
13. Doyle TJ, Hunninghake GM, Rosas IO. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med. 2012; 185 (11): 1147-1153.
14. Doyle TJ, Dellaripa PF, Batra K, et al. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014; 146 (1): 41-50.